A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis
Recruiting now · Not applicable
Conditions studied: Bronchiectasis Adult, Bronchiectasis With Acute Exacerbation, Bronchiectasis With Chronic Infection With Pseudomonas Aeruginosa, Viral Infection, Rhinovirus Infection
In brief
The goal of this study is to determine if viral infection with the common cold leads to an exacerbation in participants with bronchiectasis. The investigators will compare the participants with bronchiectasis to a group of healthy participants. The main questions it aims to answer are: * Does viral infection with the common cold lead to an exacerbation in bronchiectasis? * Does the immune response differ to that of a healthy participant? Participants will attend for a screening visit to see if they are eligible. All participants who are eligible and have consented to take part will have baseline investigations done including blood tests and a bronchoscopy. They will be given a spray of a virus that causes the common cold into their nose. They will then be followed up over the next 6 weeks with some of the following procedures at each study visit; spirometry, nasosorption, nasal lavage, nasal brushing, blood test, sputum collection and a bronchoscopy. Participants will be asked to keep a daily record of their symptoms throughout the study.
Key facts
- Study ID
- NCT06931002
- Run by
- Imperial College London
- People needed
- 54
- Starts
- 2024-07-24
- Expected to finish
- 2027-10-30
- Last updated by the study team
- 2025-07-09
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- For healthy volunteers:
- Age 18 to 65 years.
- For bronchiectasis study subjects:
- Confirmed diagnosis of bronchiectasis aged 18-65 years with bronchiectasis severity index score of 0-8 .
- For Pseudomonas colonised individuals, isolation of Pseudomonas aeruginosa in two or more cultures, at least 3 months apart in a 2-year period.
You may not qualify if…
- For healthy volunteers and bronchiectasis study subjects:
- Any medical co-morbidity impacting the study in the opinion of the medical team
- Current smoking history within last 12 months or ex smoking history >5 pack years
- Pre-existing serum neutralising antibodies to RV-A16 (strain to be used for challenge)
- Close contact with infants or elderly individuals either at home or workplace
- Pregnancy or breastfeeding
- For bronchiectasis study subjects:
- Individuals with bronchiectasis secondary to cystic fibrosis, primary immunodeficiency, primary ciliary dyskinesia and allergic bronchopulmonary aspergillosis 2) Individuals with other significant chronic lung disease diagnoses (eg. interstitial lung disease) which would impact the study in the opinion of the medical team 4) FEV1 < 50% predicted 8) Recent antibiotics for exacerbations within the preceding 6 weeks and prophylactic antibiotics (azithromycin or nebulised antibiotics) within preceding 4 weeks 9) Corticosteroid use (inhaled, nasal or systemic) within preceding 4 weeks.
Where it is running
- St Mary's Hospital - Imperial Clinical Respiratory Research Unit (ICRRU) — London, United Kingdom (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.